Civil service commission

The Women’s Forum for the Economy and Society to Hold First U.S. Event, in Partnership with Vital Voices, to Focus on Climate, Peace & Health Advocacy

Retrieved on: 
Lundi, mars 27, 2023
White House, Climate, Communication, European Central Bank, United Nations, Covington & Burling, Civil service commission, UNHCR Goodwill Ambassador, Policy, Publicis, Woman, Central bank, Research, Digital Economy and Society Index, History, Former, Organization, Planned Parenthood, Vital, United, Vital Voices, UN, Academy Awards, Fellow, Supervisory board, G20, Netflix, European Commission, Economy, Management, Health, G7

Over 200 leaders and personalities will convene at Vital Voices Global Headquarters for Women's Leadership in Washington, D.C. for a day promoting the work of women who are driving sustainable progress.

Key Points: 
  • Over 200 leaders and personalities will convene at Vital Voices Global Headquarters for Women's Leadership in Washington, D.C. for a day promoting the work of women who are driving sustainable progress.
  • “The Women’s Forum and Vital Voices are both organizations that aim to empower women and promote gender equality globally.
  • “We are proud to partner with the Women’s Forum and host their Women’s Forum USA at our global headquarters in Washington, DC.
  • The solutions we seek in climate, health and peace will require collaboration, communication, and community.”

Amicus Therapeutics Announces European Commission Approval for Pombiliti™ in Patients with Late-Onset Pompe Disease

Retrieved on: 
Lundi, mars 27, 2023
Civil service commission, Advanced Therapy Medicinal Product, Glycogen storage disease type II, European Commission, Committee, Miglustat, ERT, Patient, Physician, Committee for Medicinal Products for Human Use, Rare, Amicus Therapeutics, Enzyme replacement therapy, Therapy, EC, PROPEL, Caregiver, CHMP, Pharmaceutical industry, EU, Cipaglucosidase alfa

PHILADELPHIA, March 27, 2023 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD), a patient-dedicated global biotechnology company focused on developing and commercializing novel medicines for rare diseases, today announced that the European Commission (EC) has granted approval for Pombiliti™ (cipaglucosidase alfa), a long-term enzyme replacement therapy (ERT) used in combination with miglustat for adults with late-onset Pompe disease (LOPD). The Company has submitted the previously requested analytical testing for miglustat, the enzyme stabilizer component of AT-GAA. The Committee for Medicinal Products for Human Use (CHMP) opinion for miglustat is expected in the second quarter of 2023.

Key Points: 
  • The Committee for Medicinal Products for Human Use (CHMP) opinion for miglustat is expected in the second quarter of 2023.
  • “Late-onset Pompe disease is a rare, neuromuscular disorder that can have devastating consequences for patients and their families.
  • The European Commission approval for Pombiliti is another major step towards bringing this much needed, new treatment for all adults living in the EU with late-onset Pompe disease.
  • The EC approval of Pombiliti follows the positive opinion previously granted by the Committee for Medicinal Products for Human Use (CHMP).

Charles River Associates (CRA) Announces Vice President Promotions

Retrieved on: 
Mardi, mars 28, 2023
Consulting, Legal, Professional Services, Finance, Vaccine, Competition law, Analytical Center for the Government of the Russian Federation, CRAI, Specialization, CMA, ICSID, Civil service commission, Telecommunications, Intellectual property, Head, Gene editing, Prescription, Intelligence, CRA International, Pharmacy, United States International Trade Commission, Competition, Economics, Patent Trial and Appeal Board, Competition (economics), Patent, Investment, Mining, CRA, Growth, Data, Rare, Neuro, Health information management, European Commission, Management, Medical device, EU

Charles River Associates (NASDAQ: CRAI), a worldwide leader in providing economic, financial, and management consulting services , today announced the promotions of six new vice presidents.

Key Points: 
  • Charles River Associates (NASDAQ: CRAI), a worldwide leader in providing economic, financial, and management consulting services , today announced the promotions of six new vice presidents.
  • Sean Sheridan in CRA’s Intellectual Property Practice, Eddie Li , Erika Sloan , and Griff Vinton in CRA’s Life Sciences Practice, and Uğur Akgün and Vicki Mertzanidou in CRA’s Antitrust & Competition Economics Practice, have been promoted to the level of vice president.
  • Eddie Li regularly leverages various data sources, including pharmacy and medical claims, affiliations, prescriptions, and sales/marketing data to inform commercial strategy.
  • Dr. Uğur Akgün specializes in applying the most advanced economic theory in merger, abuse of dominance, and dispute cases.

Factorial Energy Announces European Expansion

Retrieved on: 
Lundi, mars 27, 2023
Performance & Special Interest, EV, Electric Vehicles, Sustainability, Alternative Vehicles, Fuels, Batteries, General Automotive, Technology, Automotive, Environment, Green Technology, Automotive Manufacturing, Other Automotive, Manufacturing, Mercedes-Benz, Civil service commission, Energy, Hyundai, European Commission, Lithium, Factorial, Stellantis

Factorial Energy (Factorial), an industry leader in the development of solid-state battery technology for electric vehicle (EV) applications, announced today the establishment of a European subsidiary in Germany.

Key Points: 
  • Factorial Energy (Factorial), an industry leader in the development of solid-state battery technology for electric vehicle (EV) applications, announced today the establishment of a European subsidiary in Germany.
  • Factorial has joint development agreements with Mercedes-Benz, Stellantis, and Hyundai with the goal to accelerate production of Factorial’s solid-state battery technology, which the company believes is safer and more energy dense than current lithium-ion battery technology.
  • "This is an exciting step in Factorial’s strategic global expansion,” said Siyu Huang, CEO and Co-founder of Factorial.
  • Factorial announced operations in both South Korea and Japan last year, which add to its global footprint.

Bristol Myers Squibb Receives European Commission Approval of Sotyktu (deucravacitinib), a Once-Daily Oral Treatment for Adults With Moderate-to-Severe Plaque Psoriasis

Retrieved on: 
Mardi, mars 28, 2023
Science, Other Science, Biotechnology, Research, Pharmaceutical, General Health, Health, Clinical Trials, Apremilast, Bristol Myers Squibb, University, Civil service commission, Infection, Psoriasis, Lower respiratory tract infection, Doctor of Philosophy, BMY, Dermatology, Incidence, PSO, MD, Patient, Physician, TYK2, Common, NYSE, LTE, European Commission, Pharmaceutical industry, Deucravacitinib

The POETYK study program demonstrated a consistent safety profile in patients through three years of continuous treatment.

Key Points: 
  • The POETYK study program demonstrated a consistent safety profile in patients through three years of continuous treatment.
  • “Today’s approval is a landmark achievement as patients across Europe with moderate-to-severe plaque psoriasis will now have the opportunity to be treated with Sotyktu, the first once-daily oral option to provide significant symptom relief,” said Samit Hirawat , MD, chief medical officer, Bristol Myers Squibb.
  • Up to 90% of patients with psoriasis have psoriasis vulgaris, or plaque psoriasis, which is characterized by distinct round or oval plaques typically covered by silvery-white scales.
  • The majority of infections were non-serious and mild to moderate in severity and did not lead to the discontinuation of Sotyktu.

Organic Rankine Cycle Market to Reach USD 769.27 Million by 2032 | Global Installed Capacity of the ORC System to Surpass 4,500 Mwel, Says Extrapolate

Retrieved on: 
Lundi, mars 27, 2023
U.S. Department of Energy, Office of Inspector General, Maintenance, Letter, Completeness, Joint Research Centre, Civil service commission, U.S. Department of Defense Strategy for Operating in Cyberspace, Electricity, Procter & Gamble, Microsoft, Organic Rankine cycle, Research, Geothermal energy, USD, Natural Resources, Eavor Technologies, Wood, Plant, Investment, Intel, United Kingdom, Growth, ORC, T-Mobile, Biomass, Environment, European Commission, Renewable energy, Audit, EU, Aotearoa, Rankine

DUBAI, UAE, March 27, 2023 /PRNewswire/ -- According to Extrapolate, the Organic Rankine Cycle (ORC) Market is expected to grow significantly over the forthcoming years.

Key Points: 
  • DUBAI, UAE, March 27, 2023 /PRNewswire/ -- According to Extrapolate, the Organic Rankine Cycle (ORC) Market is expected to grow significantly over the forthcoming years.
  • The market size is predicted to increase from USD 509.8 million in 2022 to USD 769.27 million by 2032 at a CAGR of 4.2%.
  • These countries are expected to increase their installed ORC capacity in the coming years considerably.
  • Browse the Complete Report Here: https://www.extrapolate.com/energy-and-power/organic-rankine-market/87401
    The global organic rankine cycle industry is highly competitive, with several key players operating in the market.

Organic Rankine Cycle Market to Reach USD 769.27 Million by 2032 | Global Installed Capacity of the ORC System to Surpass 4,500 Mwel, Says Extrapolate

Retrieved on: 
Lundi, mars 27, 2023
U.S. Department of Energy, Office of Inspector General, Maintenance, Letter, Completeness, Joint Research Centre, Civil service commission, U.S. Department of Defense Strategy for Operating in Cyberspace, Electricity, Procter & Gamble, Microsoft, Organic Rankine cycle, Research, Geothermal energy, USD, Natural Resources, Eavor Technologies, Wood, Plant, Investment, Intel, United Kingdom, Growth, ORC, T-Mobile, Biomass, Environment, European Commission, Renewable energy, Audit, EU, Aotearoa, Rankine

DUBAI, UAE, March 27, 2023 /PRNewswire/ -- According to Extrapolate, the Organic Rankine Cycle (ORC) Market is expected to grow significantly over the forthcoming years.

Key Points: 
  • DUBAI, UAE, March 27, 2023 /PRNewswire/ -- According to Extrapolate, the Organic Rankine Cycle (ORC) Market is expected to grow significantly over the forthcoming years.
  • The market size is predicted to increase from USD 509.8 million in 2022 to USD 769.27 million by 2032 at a CAGR of 4.2%.
  • These countries are expected to increase their installed ORC capacity in the coming years considerably.
  • Browse the Complete Report Here: https://www.extrapolate.com/energy-and-power/organic-rankine-market/87401
    The global organic rankine cycle industry is highly competitive, with several key players operating in the market.

AstriVax, an innovative vaccine platform company, establishes scientific advisory board with world renowned leaders in vaccine development

Retrieved on: 
Vendredi, mars 24, 2023
Vaccine, GSK, ITM, Tick-borne encephalitis, Civil service commission, HIV, Veterinary medicine, CEPI, COVID-19, Infection, University, Ebola, Yellow fever, Global health, Research, Shingles, Doctor of Philosophy, National Immunization Technical Advisory Group, Book, RSV, European Commission, MD, Influenza vaccine, Tropical medicine, UN, Travel medicine, Vertically transmitted infection, Rabies, WHO, Hygiene, Polyclinic, UNAIDS, London School of Hygiene and Tropical Medicine, Malaria, Management, Zoster vaccine, Global Health

Leuven, Belgium, 24 March 2023 – AstriVax has announced that Dr Emmanuel Hanon will chair the company’s scientific advisory board.

Key Points: 
  • Leuven, Belgium, 24 March 2023 – AstriVax has announced that Dr Emmanuel Hanon will chair the company’s scientific advisory board.
  • Renowned infectious disease experts Dr Peter Piot and Dr Patrick Soentjens have been appointed as the first scientific advisors to the AstriVax scientific advisory board that is being composed.
  • With the support of its scientific advisory board, AstriVax will continue to build its innovative plug-and-play vaccine platform to address important unmet needs in global health.
  • Their combined experience covers the full spectrum of infectious diseases, prophylactic and therapeutic vaccine development and global health management.

TAG Turns the Tide on Ad-Supported Piracy in Europe

Retrieved on: 
Jeudi, mars 23, 2023
Online, Interactive Advertising Bureau, Intellectual property, UK, Europe and Africa Malankara Orthodox Diocese, IPR, Partnership, PBI, Civil service commission, Marketing, TAG, Bullet, Public policy, Crime, IP, Risk, Advertising, Memorandum of understanding, Memorandum, Annual report, European Commission, Pharmaceutical industry, MD

LONDON, March 23, 2023 /PRNewswire/ -- The Trustworthy Accountability Group (TAG), the world's leading programme to fight criminal activity and strengthen brand safety in digital advertising, today released the second annual report on its anti-piracy initiative, Project Brand Integrity (PBI), highlighting its continued success in reducing ad-supported piracy in Europe.

Key Points: 
  • "Criminals hide in the dark, which is why Project Brand Integrity shines a spotlight on ad-supported piracy by alerting advertisers when their ads run on IP-theft sites," said Jules Kendrick, MD, UK & Europe for TAG.
  • "While we've made great strides in the fight against ad-supported piracy in Europe, we still have a long way to go," said Peter Szyszko, Founder and CEO, White Bullet.
  • The PBI annual report also analysed the state of ad-supported piracy in Europe over the past year.
  • Affiliate marketing can also be a path to ad-supported piracy – as 14% of advertiser impressions on high-risk websites come through affiliate marketing.

Arras Minerals Comments on European Union Critical Raw Materials Act and EU Strategic Partnership With Kazakhstan

Retrieved on: 
Jeudi, mars 23, 2023
ARK, Partnership, Arras, Civil service commission, Hydrogen, Fortescue Metals Group, Metal, Soil, Comment, Copper, Union, Rio Tinto, European Commission, Rare-earth element, Uranium mining, EU, European

VANCOUVER, British Columbia, March 23, 2023 (GLOBE NEWSWIRE) -- Arras Minerals Corp. (TSX-V: ARK) is pleased to comment on the European Union Critical Raw Materials Act and specifically the EU-Kazakhstan strategic partnership on raw materials, batteries and renewable hydrogen.

Key Points: 
  • VANCOUVER, British Columbia, March 23, 2023 (GLOBE NEWSWIRE) -- Arras Minerals Corp. (TSX-V: ARK) is pleased to comment on the European Union Critical Raw Materials Act and specifically the EU-Kazakhstan strategic partnership on raw materials, batteries and renewable hydrogen.
  • Kazakhstan is one of only four countries, which also includes Canada, to have recently entered into strategic partnership agreements with the European Union (EU) focusing on critical raw materials.
  • The agreement with Kazakhstan aims to ensure the development of a secure and sustainable supply of raw materials and refined materials.
  • I would like to thank Prime Minister Smailov of Kazakhstan for his efforts and look forward to our cooperation.” (Source: COP27: European Union concludes a strategic partnership with Kazakhstan on raw materials, batteries and renewable hydrogen | EEAS Website (europa.eu) )
    Darren Klinck, President of Arras Minerals commented, “The inclusion of copper in the EU’s Critical Raw Materials and Metals list combined with the recent strategic partnership agreement between the EU and Kazakhstan further demonstrates how Kazakhstan is well positioned to develop its mineral industry alongside key partners such as Arras Minerals.